As also recommended by the ADA guidelines, metformin alone or combined with GLP-1 RA represents the first line therapy, mainly due to the effect on improving insulin resistance, weight loss and cardiovascular protective effects. The gene discussed is GLP1R; the disease is Insulin resistance.